trial · primary record
OCU500
COVID-19
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 80 |
| Primary completion | 2027-11-01 |
| Primary endpoint | Occurrence of abnormal clinical safety laboratory adverse events (AE). |
| Registry ID | NCT07536308 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:45.020Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07536308
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.